Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption.
Rubenstein JL; Kim J; Ozawa T; Zhang M; Westphal M; Deen DF; Shuman MA; Neoplasia (New York, N.Y.), 2000, vol. 2, issue 4, p 306, ISSN 15228002. ISBN 15228002.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef